Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain

Disturbed Neurotransmitter Transporter Expression in Alzheimer’s Disease Brain

(2016) Kevin H. Chen et al.   JOURNAL OF ALZHEIMERS DISEASE

Advances in Alzheimer’s Disease Drug Development

(2015) Michael S Rafii et al.   BMC Medicine

Treatment Options in Alzheimer´s Disease: The GABA Story

(2015) Maite Solas et al.   CURRENT PHARMACEUTICAL DESIGN

A UHPLC–TOF/MS method based metabonomic study of total ginsenosides effects on Alzheimer disease mouse model

(2015) Yingge Gong et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Multifunctional Tacrine Derivatives in Alzheimer’s Disease

(2014) Anna Minarini et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Pharmacological approaches for Alzheimer’s disease: neurotransmitter as drug targets

(2014) Atish Prakash et al.   Expert Review of Neurotherapeutics

Decreased platelet serotonin concentration in Alzheimer's disease with involuntary emotional expression disorder

(2014) Tatjana Prokšelj et al.   NEUROSCIENCE LETTERS

Microdialysate analysis of monoamine neurotransmitters—A versatile and sensitive LC–MS/MS method

(2013) S. Greco et al.   ANALYTICA CHIMICA ACTA

Concentration of Donepezil to the Cognitive Response in Alzheimer Disease

(2013) Yuan-Han Yang et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The effects of lignan-riched extract of Shisandra chinensis on amyloid-β-induced cognitive impairment and neurotoxicity in the cortex and hippocampus of mouse

(2013) Eun Ju Jeong et al.   JOURNAL OF ETHNOPHARMACOLOGY

Chronic Stress Induces a Selective Decrease in AMPA Receptor-Mediated Synaptic Excitation at Hippocampal Temporoammonic-CA1 Synapses

(2013) A. J. Kallarackal et al.   JOURNAL OF NEUROSCIENCE

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease

(2013) Chris G. Parsons et al.   NEUROTOXICITY RESEARCH

Liquid chromatography–tandem mass spectrometry method for determination of panel of neurotransmitters in cerebrospinal fluid from the rat model for tauopathy

(2013) Andrej Kovac et al.   TALANTA

Investigation of the Human Brain Metabolome to Identify Potential Markers for Early Diagnosis and Therapeutic Targets of Alzheimer’s Disease

(2012) Stewart F. Graham et al.   ANALYTICAL CHEMISTRY

Loss of functional GABAA receptors in the Alzheimer diseased brain

(2012) A. Limon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Amyloid Precursor Protein Processing and Alzheimer's Disease

(2011) Richard J. O'Brien et al.   Annual Review of Neuroscience

Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis

(2011) Charlene Supnet et al.   CELL CALCIUM

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

(2008) Alistair Burns et al.   LANCET NEUROLOGY